For the quarter ending 2025-09-30, OWPC had $155,005 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Effect of exchange rate changes on cash | 0 | 0 |
| Loss on early extinguishment of debt | 0 | 0 |
| Stock amortization-warrants | 0 | - |
| Amended stock warrants | 0 | - |
| Net gain (loss) | 5,265,742 | -521,582 |
| Bargain purchase gain | 6,049,860 | - |
| Depreciation expense | 148,001 | - |
| Amortization of debt discounts | 801 | 42,310 |
| Common stock issued for services | 0 | 30,000 |
| Stock options issued for services | 1 | 11,468 |
| Accounts receivable | 46,323 | -114 |
| Inventory | 54,430 | -3,792 |
| Other current assets | -177,424 | 190,667 |
| Accounts payable | 84,480 | 28,711 |
| Accrued expenses | 329,168 | 147,013 |
| Net cash used in operating activities | -144,996 | -448,841 |
| Petulo pharmaceutical sas | 0 | 0 |
| Investment in eco bio - purchase price | 415,000 | - |
| Net cash used in investment activities | -415,000 | 0 |
| Repayment from notes payable, related parties | 0 | 0 |
| Proceeds from notes payable | 0 | 0 |
| Repayments of notes payable | 0 | 0 |
| Proceeds from sale of stock | 0 | - |
| Proceeds from notes payable, related parties | 715,000 | 420,000 |
| Net cash provided by financing activities | 715,000 | 420,000 |
| Net increase (decrease) in cash | 155,005 | -28,841 |
| Cash and cash equivalents at beginning of period | 13,615 | 42,456 |
| Cash and cash equivalents at end of period | 168,620 | 13,615 |